Independence Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$226K Sell
1,527
-20
-1% -$3.1K 0.05% 89
2020
Q2
$254K Sell
1,547
-11
-0.7% -$1.69K 0.06% 79
2020
Q1
$216K Hold
1,558
0.06% 75
2019
Q4
$205K Buy
+1,558
New +$181K 0.05% 97
2019
Q2
Sell
-1,651
Closed -$214K 103
2019
Q1
$214K Buy
+1,651
New +$201K 0.06% 89

Other funds holding LLY

Independence Advisors's LLY Position: Q3 2020 in Review

Independence Advisors reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2020, selling an estimated $3.1K and leaving 1,527 shares worth $226K. The position accounts for 0.05% of the portfolio, ranked #89.

Independence Advisors first reported a position in LLY in Q1 2019 and has held it in 5 quarters since. The position peaked at $254K in Q2 2020. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Independence Advisors held 1,527 shares of Eli Lilly worth $226K as of Q3 2020.
  • Independence Advisors sold 20 Eli Lilly shares in Q3 2020, an estimated $3.1K.
  • Eli Lilly made up 0.05% of Independence Advisors's portfolio in Q3 2020, its #89 holding.
  • Independence Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 5 quarters since.
  • Independence Advisors's Eli Lilly position peaked at $254K in Q2 2020.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Independence Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.